Literature DB >> 16788910

On the O2 binding of Fe-porphyrin, Fe-porphycene, and Fe-corrphycene complexes.

Hiroyuki Nakashima1, Jun-Ya Hasegawa, Hiroshi Nakatsuji.   

Abstract

Based on our previous study for the O2 binding of the Fe-Por complex, this study investigates the O2 binding mechanism in the Fe-porphyrin isomers, Fe-porphycene (FePc), and Fe-corrphycene (FeCor) complexes. By calculating the potential energy surface of the O2 binding, the present study explains the reason for the dramatic increase of O2 affinities observed in the FePc complex. In the case of FeCor-O2, the O2 binding process includes the intersystem crossing from a triplet to singlet state, as in the FePor-O2 complex. However, FePc-O2 uses only a singlet surface. This is because the ground state of the FePc complex in the deoxy state is a triplet state, while those of FePor and FeCor are a quintet state. Such difference originates from character of the SOMO. We estimated an equilibrium constant for the O2 binding that reasonably reproduced the trend observed in the experiments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788910     DOI: 10.1002/jcc.20447

Source DB:  PubMed          Journal:  J Comput Chem        ISSN: 0192-8651            Impact factor:   3.376


  3 in total

1.  Substituent effects on geometric and electronic properties of iron tetraphenylporphyrin: a DFT investigation.

Authors:  Lu Wei; Yuanbin She; Yanmin Yu; Xiaoqian Yao; Suojiang Zhang
Journal:  J Mol Model       Date:  2011-10-28       Impact factor: 1.810

2.  Axial and equatorial ligand effects on biomimetic cysteine dioxygenase model complexes.

Authors:  Luis E Gonzalez-Ovalle; Matthew G Quesne; Devesh Kumar; David P Goldberg; Sam P de Visser
Journal:  Org Biomol Chem       Date:  2012-06-19       Impact factor: 3.876

3.  B3LYP study on reduction mechanisms from O2 to H2O at the catalytic sites of fully reduced and mixed-valence bovine cytochrome c oxidases.

Authors:  Yasunori Yoshioka; Masaki Mitani
Journal:  Bioinorg Chem Appl       Date:  2010-04-06       Impact factor: 7.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.